Lungs News and Research

RSS

Analyzing the impact of heart disease treatments on patients with CHIP

Nicholas A. Marston, MD, MPH, of the TIMI Study Group and Carl J. and Ruth Shapiro Cardiovascular Center at Brigham and Women's Hospital, is the corresponding author of a paper published in Nature Medicine, "Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials."

6 Aug 2024

Mini intestines uncover mechanisms behind COVID-19-related diarrhea and potential treatments

Working with human stem cells that form a kind of "mini intestine-in-a-dish," Johns Hopkins Medicine scientists say they have found several molecular mechanisms for COVID-19-related diarrhea, suggesting potential ways to control it.

6 Aug 2024

Increasing wildfire smoke exposure linked to higher surgical risks

Nearly 100 wildfires are currently raging throughout the country, burning more than 2 million acres.

6 Aug 2024

AI-powered tool enhances handheld ultrasound for heart imaging

A handheld, portable ultrasound probe that's the size of a fat window squeegee can peer inside your heart - but this amazing piece of technology still requires highly trained medical personnel to operate it.

6 Aug 2024

Study links over 1,100 premature deaths per year to an unregulated air pollutant in Canada

A first-of-its kind study conducted in Canada's two largest cities by McGill-led researchers has linked about 1,100 premature deaths per year to an unregulated air pollutant.

5 Aug 2024

Mucosal COVID-19 vaccine prevents airborne transmission of SARS-CoV-2

The impact of mucosal versus intramuscular vaccine immunization on airborne infection and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Syrian hamsters.

5 Aug 2024

Groundbreaking discovery reveals novel macrophages crucial for lung repair after viral infection

Researchers at the University of Liège (Belgium) have discovered a new population of macrophages, important innate immune cells that populate the lungs after injury caused by respiratory viruses.

2 Aug 2024

Study elucidates mechanisms behind G protein selectivity and efficacy in adenosine A2A receptor

In a groundbreaking study, a multinational research team led by Dr. Adnan Sljoka (RIKEN) and Prof. Akio Kitao (Tokyo Tech), in collaboration with Prof. Scott Prosser (University of Toronto), has carried out experimental and computational studies to elucidate the mechanisms behind G protein selectivity and efficacy in the human adenosine A2A receptor (A2AR).

1 Aug 2024

Indoor fireplaces linked to harmful airborne particles and health risks

During the cold winter months, it is nice to light an indoor fireplace for extra warmth or to have the occasional ‘braai’. The downside is that you may be inhaling tiny solid or liquid substances that could be harmful to your health.

1 Aug 2024

Nasal COVID-19 vaccine shows promise in preventing virus spread

The lightning-fast development of COVID-19 vaccines just months after the virus appeared was a triumph of modern science and saved millions of lives.

31 Jul 2024

Exosome-encapsulated fluorescent sensors enable advanced brain imaging in Alzheimer's research

Neurotransmitter levels in the brain can indicate brain health and neurodegenerative diseases like Alzheimer's.

31 Jul 2024

New mucus-based bioink for 3D printing functional lung tissue

Lung diseases kill millions of people around the world each year. Treatment options are limited, and animal models for studying these illnesses and experimental medications are inadequate.

30 Jul 2024

UVA researchers identify a potential treatment for respiratory symptoms of long COVID

University of Virginia School of Medicine researchers have identified a potential treatment for the respiratory symptoms of long COVID after discovering an unknown cause of the condition inside the lungs.

30 Jul 2024

Maternal immune response to flu linked to fetal brain changes

A bad case of the flu during pregnancy can increase the risk for fetal neurodevelopmental disorders such as schizophrenia and autism spectrum disorder. But it's not the virus itself doing the damage; it's the mother's immune response.

29 Jul 2024

Dogs with gallbladder disease shed light on human cystic fibrosis

A canine gallbladder disease that involves the accumulation of abnormal mucus similar to that seen in human cystic fibrosis (CF) patients is caused by improper expression of the gene associated with CF in humans.

29 Jul 2024

Enterprise Therapeutics doses first person with cystic fibrosis in Phase 2 trial for novel therapy ETD001

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of those suffering from respiratory disease, today announced dosing of the first person with cystic fibrosis (pwCF) in its Phase 2a trial of ETD001.

24 Jul 2024

Ohio State leads multi-million dollar research on long COVID solutions

A 2022 study suggesting that blocking a single molecule could protect against severe illness in COVID-19 has led to a $15 million federal grant supporting a comprehensive effort to learn more – with finding a solution to long COVID at the center of the new research.

23 Jul 2024

More types of lung cells can be infected by SARS-CoV-2 than previously thought, scientists report

Scientists at Sanford Burnham Prebys, University of California San Diego and their international collaborators have reported that more types of lung cells can be infected by SARS-CoV-2 than previously thought, including those without known viral receptors.

23 Jul 2024

E-Cigarettes and Ethanol: A Forensic Perspective on Vaping

In this interview conducted at Pittcon 2024 in San Diego, we spoke to Professor Michelle Peace about the challenges and implications of detecting ethanol in e-cigarettes for drug testing and forensic toxicology.

From Pittcon 23 Jul 2024

‘A catalyst for revolution’: Launch of Thrive looks to safeguard public health

Brisbane is positioned to become the global hub for healthy buildings with today's launch of the ARC Training Centre for Advanced Building Systems against Airborne Infection Transmission (Thrive).

23 Jul 2024

Lungs News and Research

Analyzing the impact of heart disease treatments on patients with CHIP

Mini intestines uncover mechanisms behind COVID-19-related diarrhea and potential treatments

Increasing wildfire smoke exposure linked to higher surgical risks

AI-powered tool enhances handheld ultrasound for heart imaging

Study links over 1,100 premature deaths per year to an unregulated air pollutant in Canada

Mucosal COVID-19 vaccine prevents airborne transmission of SARS-CoV-2

Groundbreaking discovery reveals novel macrophages crucial for lung repair after viral infection

Study elucidates mechanisms behind G protein selectivity and efficacy in adenosine A2A receptor

Indoor fireplaces linked to harmful airborne particles and health risks

Nasal COVID-19 vaccine shows promise in preventing virus spread

Exosome-encapsulated fluorescent sensors enable advanced brain imaging in Alzheimer's research

New mucus-based bioink for 3D printing functional lung tissue

UVA researchers identify a potential treatment for respiratory symptoms of long COVID

Maternal immune response to flu linked to fetal brain changes

Dogs with gallbladder disease shed light on human cystic fibrosis

Enterprise Therapeutics doses first person with cystic fibrosis in Phase 2 trial for novel therapy ETD001

Ohio State leads multi-million dollar research on long COVID solutions

More types of lung cells can be infected by SARS-CoV-2 than previously thought, scientists report

E-Cigarettes and Ethanol: A Forensic Perspective on Vaping

‘A catalyst for revolution’: Launch of Thrive looks to safeguard public health

The ultimate guide to lung research tools and protocols eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News